Pharma Pulse: Amazon Pharmacy Sells Oral Wegovy, J&J’s Billion-Dollar Hub, and the Debt-Housing Crisis

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.

• First, Amazon Pharmacy is now offering the first oral GLP-1 for weight management. Following the FDA’s recent approval of the Wegovy pill, Amazon has launched the medication nationwide with same-day delivery in select cities. Eligible customers can pay as little as $25 with insurance, or a cash price of $149 per month for starting doses.
• Turning to the supply chain, Johnson & Johnson has announced a second $2 billion facility in Wilson, North Carolina. This marks J&J’s third major project in the state in just over a year, creating up to 500 jobs focused on advanced medicines for oncology and neurological diseases.
• Lastly, we look at the human cost of the healthcare affordability crisis. A new study in JAMA Network Open warns that medical debt is now a primary driver of housing instability. Adults carrying health-related debt are significantly more likely to face difficulty paying rent, eviction, or foreclosure in the following year.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.